Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Elvitegravir Cobicistat Emtricitabine Tenofovir Disoproxil Fumarate Drug Combination
2. Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate
3. Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate Drug Combination
4. Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
5. Elvitegravir-cobicistat-emtricitabine-tenofovir Disoproxil Fumarate Drug Combination
6. Genvoya
7. Pill, Quad
8. Quad Pill
1. Cobicistat & Elvitegravir & Emtricitabine & Tenofovir Disoproxil Fumarate
2. Cobicistat + Elvitegravir + Emtricitabine + Tenofovir Disoproxil Fumarate
3. Cobicistat And Elvitegravir And Emtricitabine And Tenofovir Disoproxil Fumarate
4. Quad
5. Quad Pill
6. Quad Tablet
7. Evg-cobi-ftc-tdf
8. Cobicistat, Elvitegravir, Emtricitabine, Tenofovir
9. Cobicistat / Elvitegravir / Emtricitabine / Tenofovir Disoproxil
10. Elvitegravir-cobicistat-emtricitabine-tenofovir Disoproxil Fumarate
11. Cobicistat / Elvitegravir / Emtricitabine / Tenofovir Disoproxil Fumarate
12. Cobicistat Mixture With Elvitegravir And Emtricitabine And Tenofovir Disoproxil
13. Cobicistat Mixture With Elvitegravir, Emtricitabine And Tenofovir Disoproxil Fumarate
14. Elvitegravir Mixture With Cobicistat And Emtricitabine And Tenofovir Disoproxil Fumarate
15. Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
16. 1430117-57-9
| Molecular Weight | 2106.7 g/mol |
|---|---|
| Molecular Formula | C94H120ClF2N16O27PS3 |
| Hydrogen Bond Donor Count | 10 |
| Hydrogen Bond Acceptor Count | 40 |
| Rotatable Bond Count | 48 |
| Exact Mass | 2105.7098720 g/mol |
| Monoisotopic Mass | 2104.7065172 g/mol |
| Topological Polar Surface Area | 655 Ų |
| Heavy Atom Count | 144 |
| Formal Charge | 0 |
| Complexity | 3010 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 7 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 5 |
| 1 of 2 | |
|---|---|
| Drug Name | Stribild |
| PubMed Health | Elvitegravir/Cobicistat/Emtricitabine/Tenofovir (By mouth) |
| Drug Classes | Anti-Infective Agent, Antiviral, Reverse Transcriptase Inhibitor Combination |
| Drug Label | STRIBILD is a fixed-dose combination tablet containing elvitegravir, cobicistat, emtricitabine, and tenofovir DF for oral administration.Elvitegravir is an HIV-1 integrase strand transfer inhibitor.Cobicistat is a mechanism-based inhibitor of cytochr... |
| Active Ingredient | elvitegravir; Cobicistat; tenofovir disoproxil fumarate; emtricitabine |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 200mg; 150mg; 300mg |
| Market Status | Prescription |
| Company | Gilead Sciences |
| 2 of 2 | |
|---|---|
| Drug Name | Stribild |
| PubMed Health | Elvitegravir/Cobicistat/Emtricitabine/Tenofovir (By mouth) |
| Drug Classes | Anti-Infective Agent, Antiviral, Reverse Transcriptase Inhibitor Combination |
| Drug Label | STRIBILD is a fixed-dose combination tablet containing elvitegravir, cobicistat, emtricitabine, and tenofovir DF for oral administration.Elvitegravir is an HIV-1 integrase strand transfer inhibitor.Cobicistat is a mechanism-based inhibitor of cytochr... |
| Active Ingredient | elvitegravir; Cobicistat; tenofovir disoproxil fumarate; emtricitabine |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 200mg; 150mg; 300mg |
| Market Status | Prescription |
| Company | Gilead Sciences |
Treatment of human immunodeficiency virus 1 (HIV 1) infection in adults aged 18 years and over who are antiretroviral treatment-nave or are infected with HIV 1 without known mutations associated with resistance to any of the three antiretroviral agents in Stribild.
Anti-HIV Agents
Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. (See all compounds classified as Anti-HIV Agents.)
J05AR09
Digital Content 
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
A Quad Tablet manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Quad Tablet, including repackagers and relabelers. The FDA regulates Quad Tablet manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Quad Tablet API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Quad Tablet supplier is an individual or a company that provides Quad Tablet active pharmaceutical ingredient (API) or Quad Tablet finished formulations upon request. The Quad Tablet suppliers may include Quad Tablet API manufacturers, exporters, distributors and traders.
Quad Tablet Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Quad Tablet GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Quad Tablet GMP manufacturer or Quad Tablet GMP API supplier for your needs.
A Quad Tablet CoA (Certificate of Analysis) is a formal document that attests to Quad Tablet's compliance with Quad Tablet specifications and serves as a tool for batch-level quality control.
Quad Tablet CoA mostly includes findings from lab analyses of a specific batch. For each Quad Tablet CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Quad Tablet may be tested according to a variety of international standards, such as European Pharmacopoeia (Quad Tablet EP), Quad Tablet JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Quad Tablet USP).
LOOKING FOR A SUPPLIER?
